Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile

被引:7
|
作者
Zhang, Min [1 ]
Li, Kun [1 ]
Qu, Shoufang [2 ]
Guo, Zhiwei [1 ]
Wang, Yuanli [3 ]
Yang, Xu [1 ]
Zhou, Junhua [3 ]
Ouyang, Guojun [3 ]
Weng, Rongtao [3 ]
Li, Fenxia [4 ]
Wu, Yingsong [1 ]
Yang, Xuexi [1 ]
机构
[1] Southern Med Univ, Sch Lab Med & Biotechnol, Inst Antibody Engn, 1838 N Guangzhou Ave, Guangzhou 510515, Peoples R China
[2] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China
[3] Guangzhou Darui Biotechnol Co Ltd, Guangzhou 510665, Guangdong, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Peoples R China
关键词
Plasma cell free DNA; Aneuploid fetus; Trisomy pregnancy; Nucleosome footprints; Gene expression profiles; OF-FUNCTION MUTATIONS; FETAL DNA; MECHANISMS; SUPPRESSION; DISORDERS; FRACTION; DELETION; TISSUES; ROLES; SERUM;
D O I
10.1186/s12967-022-03735-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Chromosomal aneuploidy is the most common birth defect. However, the developmental mechanism and gene expression profile of fetuses with chromosomal aneuploidy are relatively unknown, and the maternal immune changes induced by fetal aneuploidy remain unclear. The inability to obtain the placenta multiple times in real-time is a bottleneck in research on aneuploid pregnancies. Plasma cell-free DNA (cfDNA) carries the gene expression profile information of its source cells and may be used to evaluate the development of fetuses with aneuploidy and the immune changes induced in the mother owing to fetal aneuploidy. Methods Here, we carried out whole-genome sequencing of the plasma cfDNA of 101 pregnant women carrying a fetus with trisomy (trisomy 21, n = 42; trisomy 18, n = 28; trisomy 13, n = 31) based on non-invasive prenatal testing (NIPT) screening and 140 normal pregnant women to identify differential genes according to the cfDNA nucleosome profile in the region around the transcription start sites (TSSs). Results The plasma cfDNA promoter profiles were found to differ between aneuploid and euploid pregnancies. A total of 158 genes with significant differences were identified, of which 43 genes were upregulated and 98 genes were downregulated. Functional enrichment and signaling pathway analysis were performed based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases found that these signal pathways were mainly related to the coordination of developmental signals during embryonic development, the control of cell growth and development, regulation of neuronal survival, and immune regulation, such as the MAPK, Hippo, TGF-beta, and Rap1 signaling pathways, which play important roles in the development of embryonic tissues and organs. Furthermore, based on the results of differential gene analysis, a total of 14 immune-related genes with significant differences from the ImmPort database were collected and analyzed. These significantly different immune genes were mainly associated with the maintenance of embryonic homeostasis and normal development. Conclusions These results suggest that the distribution characteristics of cfDNA nucleosomes in maternal plasma can be used to reflect the status of fetal development and changes of the immune responses in trisomic pregnancies. Overall, our findings may provide research ideas for non-invasive detection of the physiological and pathological states of other diseases.
引用
收藏
页数:12
相关论文
共 37 条
  • [1] Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile
    Min Zhang
    Kun Li
    Shoufang Qu
    Zhiwei Guo
    Yuanli Wang
    Xu Yang
    Junhua Zhou
    Guojun Ouyang
    Rongtao Weng
    Fenxia Li
    Yingsong Wu
    Xuexi Yang
    Journal of Translational Medicine, 20
  • [2] Maternal plasma cell-free DNA nucleosome footprints can reveal changes in gene expression profiles during pregnancy and pre-eclampsia
    Li, Kun
    Guo, Zhiwei
    Li, Fenxia
    Lu, Shijing
    Zhang, Min
    Wei, Xingyu
    Sheng, Chao
    Hao, Wenbo
    Yang, Xuexi
    BMC PREGNANCY AND CHILDBIRTH, 2025, 25 (01)
  • [3] Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma
    Porreco, Richard P.
    Sekedat, Matthew
    Bombard, Allan
    Garite, Thomas J.
    Maurel, Kimberly
    Marusiak, Barbara
    Adair, David
    Bleich, April
    Combs, C. Andrew
    Kramer, Wayne
    Longo, Sherri
    Nageotte, Michael
    Samuel, Amber
    Vanderhoeven, Jeroen
    Buis, Jeff
    Jacobs, Kevin B.
    Stoerker, Jay
    JOURNAL OF MEDICAL SCREENING, 2020, 27 (01) : 1 - 8
  • [4] Role of cell-free fetal DNA in the maternal plasma in the prenatal diagnosis of chromosomal abnormalities
    Lu, Rong
    Xu, Hui
    Chen, Xin
    Wang, Yuanlin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11740 - 11747
  • [5] Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma
    Mazloom, Amin R.
    Dzakula, Zeljko
    Oeth, Paul
    Wang, Huiquan
    Jensen, Taylor
    Tynan, John
    McCullough, Ron
    Saldivar, Juan-Sebastian
    Ehrich, Mathias
    van den Boom, Dirk
    Bombard, Allan T.
    Maeder, Margo
    McLennan, Graham
    Meschino, Wendy
    Palomaki, Glenn E.
    Canick, Jacob A.
    Deciu, Cosmin
    PRENATAL DIAGNOSIS, 2013, 33 (06) : 591 - 597
  • [6] Maternal plasma DNA sequencing: effects of multiple gestation on aneuploidy detection and the relative cell-free fetal DNA (cffDNA) per fetus
    Srinivasan, Anupama
    Bianchi, Diana
    Liao, Wayne
    Sehnert, Amy
    Rava, Richard
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S31 - S31
  • [7] Non-invasive determination of gene expression in placental tissue using maternal plasma cell-free DNA fragmentation characters
    Li, Kun
    Guo, Zhiwei
    Li, Fenxia
    Lu, Shijing
    Zhang, Min
    Gong, Yuyan
    Tan, Jiayu
    Sheng, Chao
    Hao, Wenbo
    Yang, Xuexi
    GENE, 2024, 928
  • [8] A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection
    Xu, Xu-Ping
    Gan, Hai-Yan
    Li, Fen-Xia
    Tian, Qi
    Zhang, Jun
    Liang, Rong-Liang
    Li, Ming
    Yang, Xue-Xi
    Wu, Ying-Song
    PLOS ONE, 2016, 11 (01):
  • [9] Gene expression analysis of MMPs in women with preeclampsia using cell-free fetal RNA in maternal plasma
    Etesami, Elham
    Nikukar, Habib
    Ramezanali, Fariba
    Vandani, Fahimeh Ghotbizadeh
    Shahhoseini, Maryam
    Favaedi, Raha
    Ghaheri, Azadeh
    Seydabadi, Sara
    Zamanian, Mohammadreza
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2019, 17 : 261 - 268
  • [10] Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factors
    Yu, Yan
    Xu, Wenqiu
    Zhang, Sufen
    Feng, Suihua
    Feng, Feng
    Dai, Junshang
    Zhang, Xiao
    Tian, Peirun
    Wang, Shunyao
    Zhao, Zhiguang
    Zhao, Wenrui
    Guan, Liping
    Qiu, Zhixu
    Zhang, Jianguo
    Peng, Huanhuan
    Lin, Jiawei
    Zhang, Qun
    Chen, Weiping
    Li, Huahua
    Zhao, Qiang
    Xiao, Gefei
    Li, Zhongzhe
    Zhou, Shihao
    Peng, Can
    Xu, Zhen
    Zhang, Jingjing
    Zhang, Rui
    He, Xiaohong
    Li, Hua
    Li, Jia
    Ruan, Xiaohong
    Zhao, Lijian
    He, Jun
    FRONTIERS IN MEDICINE, 2024, 11